Human cAMP-dependent protein kinase beta-catalytic subunit

US7112426B2 · kind B2 · utility

Assignee

• Incyte Corporation · US

Inventors

• Olga Bandman · Mountain View, US
• Danniel Nguyen · San Jose, US
• Narinder Chawla · Union City, US
• April Hafalia · Pacifica, US
• Monique Yao · Mountain View, US
• Ameena Gandhi · San Francisco, US
• Rajagopal Gururajan · San Jose, US
• Li Ding · Creve Coeur, US
• Chandra Arvizu · San Diego, US
• Henry Yue · Sunnyvale, US
• Mariah Baughn · San Jose, US
• Catherine Tribouley · San Francisco, US
• Michael Thornton · Oakland, US
• Vicki Elliott · San Jose, US
• Yan Lu · Mountain View, US
• Craig Ison · San Jose, US
• Janice Au-Young · Brisbane, US
• Y Tang · San Jose, US
• Yalda Azimzai · Union City, US
• John Burrill · Redwood City, US
• Gregory Marcus · Redwood City, US
• Kurt Zingler · San Francisco, US
• Dyung Lu · San Jose, US
• Preeti G Lai · Santa Clara, US
• Jayalaxmi Ramkumar · Fremont, US
• Bridget Warren · Cupertino, US
• Liam Kearney · San Francisco, US
• Jennifer Policky · San Jose, US
• Kavitha Thangavelu · Sunnyvale, US
• Neil Burford · Durham, US

Key dates

• Filing date: Nov 1, 2002
• Grant date: Sep 26, 2006
• Expiry date: Jul 19, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A01K2217/05
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.